glp-1 deficiency therapy is becoming a widespread pharmaceutical treatment for obesity and type 2 diabetes, but there are side effects. Many users develop deficiencies in critical nutrients like vitamin D, iron, and B Glucagon-like peptide 1 (GLP-1) -
Description
The term came from the people taking these medications, not from textbooks, and the science is catching up - researchers published the first formal clinical definition in 2025, describing persistent, intrusive thoughts about food that interfere with daily life
Semaglutide was associated with gastrointestinal adverse events (nausea, vomiting, diarrhea, constipation) which were of mild to moderate severity, short duration, and resolved without treatment discontinuation ( Notably, a recent systematic review showed that compared to other semaglutide doses and GLP-1 RAs, 2.4 mg semaglutide had the greatest effect on weight reduction, controlling glucose level, and reducing BP
Gutgesell RM, et al
Understanding the probiotic health benefits of Bifidobacterium animalis subsp
In some cases, they are not even sure whether they are receiving an FDA-approved drug or a compounded alternative
There is a risk of weight regain if the medication is discontinued
